Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Study finds antibodies target different parts of SARS-CoV-2 in severe COVID-19 cases
People with severe COVID-19 have lower levels of antibodies targeting the spike protein used by the virus to enter human cells…
US doctor develops severe allergic reaction to Moderna COVID-19 vaccine, reports NYT
It is the first severe reaction publicly linked to Moderna’s vaccine, which is in its first week of rollout in the US
Vice President Venkaiah Naidu meets Bharat Biotech CMD, discusses status of Covaxin
Naidu stressed the importance of PPPs in coming out with indigenous world-class products
USFDA defers action on BLA for Avastin biosimilar, notifies Biocon Biologics, Mylan
To complete the application, the agency noted that an inspection of the manufacturing facility is required as a part of the…
Pharma industry urges government to extend MEIS scheme till March 2021
Since April 2020, the Indian pharma industry is facing a challenge in availing the MEIS benefits
Dry run for COVID-19 vaccine administration in four states next week: Govt
An important focus of the dry run will be on management of any possible adverse events following immunisation (AEFI)
M&As in bio/pharma industry high despite COVID-19: GlobalData
Down only 13 per cent compared with last year, with a total deal value of $228 billion compared with $262 billion in 2020, and…
Zydus seeks approval for Phase III clinical trials of ZyCoV-D, submits Phase I/II clinical trial…
ZyCoV-D was found to be safe, well tolerated and immunogenic in the Phase I/II clinical trials, informs company
Lupin gets tentative approval from USFDA for Efinaconazole Topical Solution
It is indicated for the topical treatment of onychomycosis of the toenail(s) due to Trichophyton rubrum and Trichophyton…
Serbia begins COVID-19 vaccination drive, with PM first in line
The Prime Minister Ana Brnabic received Serbia’s first COVID-19 vaccine shot, kicking off a mass inoculation drive with doses…